Chaperonin 10 immunosuppression

Details Chaperonin 10 immunosuppression Chaperonin 10 immunosuppression

2009-10-01

2011-11-29

Schwadron, Ronald (Department: 1644)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S885000, C514S020500, C530S350000, C530S380000

Reexamination Certificate

active

08067361

ABSTRACT:
The invention is directed to the use of cpn10 in transplantation and particularly to treatment and/or prevention of graft versus host disease. The invention provides a method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor, although in a particularly advantageous form treatment of both the donor and recipient animal. The method may further include the administration to the donor and/or recipient animal at least one other immunosuppressive agent to prevent or alleviate graft versus host disease.

REFERENCES:
patent: 5989804 (1999-11-01), Androphy et al.
patent: 6117421 (2000-09-01), Morton et al.
patent: 6417334 (2002-07-01), Morton et al.
patent: WO 95/15338 (1995-06-01), None
patent: WO 01/17554 (2001-03-01), None
patent: WO 02/40038 (2002-05-01), None
Chen et al., “Isolation, sequence analysis and characterization of a cDNA encoding human chaperonin 10” Biochim. Biophys. Acta, 1219, 189-190 (1994).
Cooke et al., “LPS antagonism reduces graft-versus host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.” J. Clin. Invest., 107, 1581-1589 (2001).
Cooke et al, “Hyporesponsiveness of Donor Cells to Lipopolysaccharide Stimulation Reduces the Severity of Experimental Idoiopathic Pneumonia Syndrome: Potential Role for a Gut-Lung Axis of Inflammation.” J. Immunol., 165, 6612-6619, (2000).
Cooke et al, “An Experimental Model of Idiopathic Pneumonia Syndrome After Bone Marrow Transplantaion: I. The Roles of Minor H Antigens and Endotoxin.” Blood, 88, 3230-3239 (1996).
Dickson et al., “Cloning, Expression, and Purification of a Functional Nonacetylated Mammalian Mitochondrial Chaperonin 10.” J. Biol. Chem., 269, 26858-864, (1994).
Ellis et al., “Molecular Chaperones.” Annu. Rev. Biochem. 60, 321-47, (1991).
Hartman et al., “Identification of a mammalian 10-kDa heat shock protein, a mitochondrial chaperonin 10 homologue essential for assisted folding of trimeric ornithine transcarbamoylase in vitro.” Proc. Natl. Acad. Sci. USA, 89, 3394-8, (1992).
Hill et al., “Interleukin-11 Promotes T Cell Polarization and Prevents Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation.” J. Clin. Invest., 102, 115-123 (1998).
Hill et al., “Total Body Irradiation and Acute Graft-Versus-Host disease: The role of Gastrointestinal Damage and Inflammatory Cytokines.” Blood, 90, 3204-3213, (1997).
Hill et al, “Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia.” J. Clin. Invest., 104, 459-467, (1999).
Kimura et al., The Journal of Int. Med. Res., 29:214-221, 2001.
Krijanovski et al, “Keratinocyte Growth Factor Separates Graft-Versus-Leukemia Effects From Graft-Versus-Host Disease.” Blood, 94, 825-831, (1999).
Morton et al., “Immunosuppression detected in pregnant mice by rosette inhibition test.” Nature, 249; 459-460, (1974).
Morton et al., “Studies of the Rosette Inhibition Test in Pregnant Mice: Evidence of Immunosuppression?” Proc. R. Soc. Land., 193; 413-9, (1976).
Morton et al., “Recent Advances in Mammalian Development.” Current Topics in Developmental Biology, 23; 73-92 (1987).
Morton H., “Early pregnancy factor: An extracellular chaperonin 10 homologue.” Immunol. Cell Biol., 76, 483-496, (1998).
Morton et al., Production of a recombinant form of early pregnancy factor that can prolong allogeneic skin graft survival time in rats. Immunology and Cell Biology, 78:6, p. 603-607, Dec. 2000. XP002463561.
Noonan et al., “Early pregnancy factor is immunosuppressive.” Nature, 278, 649-51, (1979).
Ogita et al., “Stress Responses in Graft and Native Intestine After Rat Heterotopic Small Bowel Transplantaion.” Transplantation, 69, 2273-2277, (2000).
Rolfe et al., “Identification of two suppressor factors induced by early pregnancy factor.” Clin. Exp. Immunol., 73, 2 19-225, (1988).
Ryan et al., “Isolation of a cDNA clone specifying rat chaperonin 10, a stress-inducible mitochondrial matrix protein synthesised without a cleavable presequence.” FEBS Lett., 337, 152-156 (1994).
Speiser et al., “TNF Receptor p55 Controls Early Acute Graft-Versus-Host Disease.” J. Immunol., 158, 5185-5190, (1997).
Somodevilla-Torres et al., Prot. Exp. And Purif., 32:276-287, 2003 (available online Oct. 2003).

Affiliated with

Also associated with

Rating

Chaperonin 10 immunosuppression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chaperonin 10 immunosuppression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chaperonin 10 immunosuppression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4257974